Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175991 | SCV000227571 | pathogenic | not provided | 2014-09-16 | criteria provided, single submitter | clinical testing | |
Molecular Biology Laboratory, |
RCV001281248 | SCV001425120 | pathogenic | Nephronophthisis 3 | 2020-02-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001852163 | SCV002241361 | pathogenic | Nephronophthisis | 2024-09-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu145Valfs*3) in the NPHP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP3 are known to be pathogenic (PMID: 18371931, 23559409). This variant is present in population databases (rs763300393, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of nephronophthisis (PMID: 23188109). ClinVar contains an entry for this variant (Variation ID: 195423). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000175991 | SCV002552616 | pathogenic | not provided | 2022-07-11 | criteria provided, single submitter | clinical testing | Reported in published literature as a positive result for a patient undergoing exome sequencing, but further clinical information was not provided (Farwell et al., 2015); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 25356970, 23188109) |
Fulgent Genetics, |
RCV002500482 | SCV002810844 | pathogenic | Renal-hepatic-pancreatic dysplasia 1; Nephronophthisis 3; NPHP3-related Meckel-like syndrome | 2021-12-23 | criteria provided, single submitter | clinical testing |